These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9070296)

  • 1. Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells.
    Pirillo A; Jacoviello C; Longoni C; Radaelli A; Catapano AL
    Biochem Biophys Res Commun; 1997 Feb; 231(2):437-41. PubMed ID: 9070296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
    Corsini A; Arnaboldi L; Quarato P; Ferri N; Granata A; Fumagalli R; Paoletti R
    C R Seances Soc Biol Fil; 1997; 191(2):169-94. PubMed ID: 9255346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
    Peffley DM; Gayen AK
    Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
    Laufs U; La Fata V; Plutzky J; Liao JK
    Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
    Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol.
    Loike JD; Shabtai DY; Neuhut R; Malitzky S; Lu E; Husemann J; Goldberg IJ; Silverstein SC
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2051-6. PubMed ID: 15345508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
    Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
    Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
    Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
    Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
    Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
    Guyton JR; Lenz ML; Mathews B; Hughes H; Karsan D; Selinger E; Smith CV
    Atherosclerosis; 1995 Dec; 118(2):237-49. PubMed ID: 8770318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
    Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating.
    Zhu W; Roma P; Pirillo A; Pellegatta F; Catapano AL
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1104-11. PubMed ID: 8792763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
    Wentzinger LF; Bach TJ; Hartmann MA
    Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of host cell cholesterol de novo biosynthesis and processing abrogates Eimeria bovis intracellular development.
    Hamid PH; Hirzmann J; Hermosilla C; Taubert A
    Parasitol Res; 2014 Nov; 113(11):4165-76. PubMed ID: 25199551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells.
    Pirillo A; Zhu W; Roma P; Galli G; Caruso D; Pellegatta F; Catapano AL
    FEBS Lett; 1999 Nov; 462(1-2):113-6. PubMed ID: 10580102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.